Prostate Cancer Key Statistics
transcription factors such as AR, Sp1, STATs, E2F, Egr1, c-Myc, HIF-1卤, NF-B, AP-1, ETS2, GLI and p53 in the context of prostate cancer ... M Kaur,R Agarwal - 《Curr Cancer Drug Targets》 被引量: 125发表: 2007年 Prostate cancer incidence statistics Prostate Cancer Incidence S...
[6] https://www.cancer.org/cancer/types/lung-cancer/detection-diagnosis-staging/survival-rates.html [7] https://my.clevelandclinic.org/health/diseases/4375-lung-cancer [8] The SEER Cancer Statistics Review 1975-2015. Surveillance, Epidemiology, and End Results (SEER), U.S....
(2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394–424. PubMed Google Scholar Jin, K., et al. (2020). An update on colorectal cancer microenvironment, epigenetic...
IBM SPSS Statistics https://www.ibm.com/support/pages/downloading-ibm-spss-statistics-26 (2022) Google Scholar [45] K.A.-O.X. Pii, L.A.-O. Schou, K.A.-O. Piil, M.A.-O. Jarden Current trends in patient and public involvement in cancer research: a systematic review (2018) (136...
Moreover, gender itself is a highly relevant category in cancer screening, as the healthcare service offers differ for men and women. For instance, early detection screening for breast and cervical cancers are targeted at women, while there is a focus on men for prostate cancer screening, ...
Cancer statistics for the year 2020: an overview. Int J Cancer. 2021. Harbeck N, Thomssen C, Gnant M. St. Gallen 2013: brief preliminary summary of the consensus discussion. Breast Care (Basel). 2013;8(2):102–9. Collignon J, Lousberg L, Schroeder H, Jerusalem G. Triple-negative ...
Squamous cell carcinoma (SCC) and adenocarcinoma (AC) are two main histological subtypes of solid cancer; however, SCCs are derived from different organs with similar morphologies, and it is challenging to distinguish the origin of metastatic SCCs. Here we report a deep proteomic analysis of 333 ...
[148,149]. PARP inhibitors are effective in patients carrying germline BRCA mutations with several types of advanced cancers, including breast cancer, prostate cancer and ovarian cancer [150,151,152]. In a phase III clinical trial of 154 patients with germline BRCA-mutated metastatic pancreatic ...
In: Proceedings of the international conference on artificial intelligence and statistics, online pp 26–28 Balaha HM, Saif M, Tamer A et al (2022) Hybrid deep learning and genetic algorithms approach (HMB-DLGAHA) for the early ultrasound diagnoses of breast cancer. Neural Comput Appl 2022:...